| CTRI Number |
CTRI/2022/11/047369 [Registered on: 16/11/2022] Trial Registered Prospectively |
| Last Modified On: |
27/10/2022 |
| Post Graduate Thesis |
No |
| Type of Trial |
Observational |
|
Type of Study
|
Cohort Study |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Design and Development of decision support system for detection of breast cancer from Mammograms |
|
Scientific Title of Study
|
Design and Development of Deep Learning based system for detection of breast cancer from Digital Mammograms |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Ashwini Amin |
| Designation |
Ph.D Research Scholor |
| Affiliation |
Manipal Institute of Technology |
| Address |
Department of Computer Science Engineering
Academic Block 5
Manipal Institute of Technology(MIT),
Eshwar Nagar, Manipal,
Udupi, Karnataka-576104
Udupi KARNATAKA 576104 India |
| Phone |
7411775862 |
| Fax |
|
| Email |
ashwini.amin@learner.manipal.edu |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Dinesh Acharya U |
| Designation |
Professor |
| Affiliation |
Manipal Institute of Technology |
| Address |
Department of Computer Science Engineering
Academic Block 5
Manipal Institute of Technology(MIT),
Eshwar Nagar, Manipal,
Udupi, Karnataka-576104
Udupi KARNATAKA 576104 India |
| Phone |
9449367822 |
| Fax |
|
| Email |
dinesh.acharya@manipal.edu |
|
Details of Contact Person Public Query
|
| Name |
Dr Stanley Mathew |
| Designation |
Professor of Surgery |
| Affiliation |
Kasturba Medical College, Manipal |
| Address |
Department of Surgery,
3rd Floor,
Smt. Sharadha Madhav Pai OPD,
Kasturba Hospital
Udupi KARNATAKA 576104 India |
| Phone |
08202923728 |
| Fax |
|
| Email |
stanley.mathew@manipal.edu |
|
|
Source of Monetary or Material Support
|
| Director, Manipal Institute of Technology, Eshwar Nagar, Manipal, Udupi, Karnataka-576104 |
|
|
Primary Sponsor
|
| Name |
Ashwini Amin |
| Address |
Manipal Institute of Technology(MIT),
Eshwar Nagar, Manipal,
Udupi, Karnataka-576104 |
| Type of Sponsor |
Other [Private Institute of Technology] |
|
|
Details of Secondary Sponsor
|
| Name |
Address |
| Medical Superintendent |
Kasturba Hospital,
Madhavnagar, Manipal, Udupi, Karnataka-576104 |
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Ashwini Amin |
Kasturba Hospital, Manipal |
PACS Room 2,
Department of Radiodiagnosis,
Ground Floor,
Baliga Block,
Kasturba Hospital,
Manipal Udupi KARNATAKA |
7411775862
ashwini.amin@learner.manipal.edu |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| KMC and KH Institutional Ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: C508||Malignant neoplasm of overlappingsites of breast, (2) ICD-10 Condition: D249||Benign neoplasm of unspecified breast, (3) ICD-10 Condition: C509||Malignant neoplasm of breast of unspecified site, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Nil |
Nil |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
99.00 Year(s) |
| Gender |
Female |
| Details |
1. Patients who undergo bilateral mammography
2. Consenting individuals
3. Patients undergoing FNAC, biopsy or surgical excision for confirmation |
|
| ExclusionCriteria |
| Details |
1. Patients below 18 years and above 99 years
2. Male Patients
3. Patients who have undergone only unilateral mammography
4. Patients who do not have cytological or histopathological confirmation of diagnosis |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Positive identification of malignant and benign lesions in the mammogram using deep learning model |
30 days |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Identification of ideal parameters to incorporate into the CAD design |
30 days |
|
|
Target Sample Size
|
Total Sample Size="5500" Sample Size from India="5500"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
02/01/2023 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="3" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
Data collection not commenced. Publication is anticipated after data collection and analysis |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Informed Consent Form Response - Clinical Study Report Response - Analytic Code
- Who will be able to view these files?
Response (Others) - Researchers whose proposed use of the data has been approved by an Institutional Ethics committee identiï¬ed for this purpose, Editors of Journals and an appropriate Regulatory Authority
- For what types of analyses will this data be available?
Response - To achieve aims in the approved proposal.
- By what mechanism will data be made available?
Response (Others) - To gain access, data requestors will need to sign a data access agreement.
- For how long will this data be available start date provided 01-01-2027 and end date provided 01-01-2032?
Response - Beginning 9 months and ending 36 months following article publication.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - Nil
|
|
Brief Summary
|
Female breast cancer has become the most often diagnosed type of cancer in the world and has become a major health concern across rural and urban areas in India nowadays. Asian women are more likely to have dense breasts than other women in the world. Dense breast tissue can make it more difficult to detect breast cancer and is also linked to an increased risk of breast cancer. Digital Mammography is a very useful technique for screening and is acknowledged as the most reliable method for detecting breast cancer at an early stage, but its accuracy is limited by the radiologists’ clinical experience. To solve this problem a novel fully automated deep learning-based breast cancer computer-aided diagnosis system (CAD) enabled with a graphical user interface is proposed. Quantitative research will be conducted focusing on Digital Mammogram pre-processing, image segmentation to detect regions of interest, and classification of these images based on the Breast Imaging-Reporting and Data System (BI-RADS) using deep learning models. We propose to design a novel CAD system based on the digital mammograms available at Kasturba Hospital, Manipal Patient Archival System. In the pre-processing phase, the raw mammography images collected from the above database will be anonymized, the BI-RADS reports and the histopathology reports will be analyzed and information related to various lesions will be extracted from the reports. The final curated data will be further processed through image resizing, and conversion to other image formats for the purpose of readability by the program. The need for various de-noising and enhancement techniques will be studied using various performance evaluation parameters. In the segmentation phase, the model will be developed to detect the Region of Interest (ROI) after removing the pectoral muscles from the mediolateral oblique (MLO) view and any other artifacts which will be identified after data collection. Various traditional segmentation models and deep learning-based segmentation models will be studied and the best model based on the performance metrics will be identified. In the classification phase, the segmented image will be split into training, validation, and testing set which will be tested on various deep-learning models. The best model based on the performance will be used as the final model for the prospective testing. In the prospective testing phase we will validate the CAD in patients who consent to participate in the study and will be undergoing mammography for clinical indications |